Pilot Trial of Arsenic + Cytarabine in Patients With Myelofibrosis

NCT00572065 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Myelofibrosis

Interventions

DRUG: arsenic trioxide
DRUG: cytarabine

Sponsor

Weill Medical College of Cornell University